About Index Trending news
Analyze
Pricing
OptiNose

OptiNose

OptiNose

OptiNose develops nasal drug delivery technologies and combined drug and devicetherapies.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding
Venture capital (Series C)
$48,500,000
Employees

Team size

10+
Locations
HQ
Headquarters
PE Hub

VC-backed OptiNose debuts IPO

Stock markets Health